Taiwan Semiconductor Manufacturing Company heads into its October 16 earnings window having shed 3.4% on the week to TWD 2,385 — a controlled retreat that follows a brief intraday peak near TWD 2,470, and that leaves the core question unchanged: whether the Q3 print will validate the AI-demand narrative or expose the limits of the post-Q2 re-rating.
The lending market offers almost no signal here — and that itself is the signal. Borrow availability is essentially unlimited, with the pool of lendable shares dwarfing anything short sellers have drawn on. Fewer than 0.35% of lendable shares are actually out on loan, and that utilisation rate has barely moved in weeks. Cost to borrow is running at 0.74%, up about 18% over the past month in absolute terms but still firmly in "negligible" territory. Short interest's factor rank sits in the 96th percentile precisely because shorts are almost absent — not because they are piling in. There is no squeeze dynamic, no borrow squeeze, no meaningful bearish positioning through the stock-lending channel. This week's 3.4% dip was not short sellers expressing a view.
Valuation tells a more nuanced story. The trailing P/E has eased to roughly 18x, down about three-quarters of a point on the week as the price retreated. EV/EBITDA has compressed similarly, now near 12x. Both multiples have drifted lower over the past month — not a dramatic re-rating, but a quiet acknowledgment that last quarter's excitement has been priced in and the market is holding rather than adding. The ORTEX short score has nudged up to 25.4 from around 25.1 ten days ago, which in TSMC's case reflects the subdued but gently firming interest in borrow rather than any alarm — the score remains low in absolute terms. EPS momentum ranks in the 60th percentile on both 30- and 90-day horizons, suggesting the earnings revision cycle is positive but not exceptional. Forward EPS growth, however, ranks in just the 32nd percentile year-on-year, which points to a market already pricing in strong results and looking for upside surprises rather than simply solid execution.
Institutional ownership is broadly stable, with the top holders reporting minor additions rather than any directional shift. BlackRock added roughly 17.5 million shares through August, Capital Research added 8.5 million, and Vanguard added around 8.6 million. None of these moves are dramatic relative to position sizes above 900 million shares, but the direction is uniformly incremental buying rather than trimming. The company's September 1 equity grants to senior vice presidents, the Co-COO, and CFO Wendell Huang were compensation awards at zero cost, carrying no read-through on management's near-term view of the stock.
The most useful context comes from the July earnings reaction: the stock fell 6.1% the day results were reported, then partially recovered to close the five-day window down just 1.4%. That pattern — an initial sharp drawdown followed by measured recovery — is worth holding in mind as October 16 approaches. The Q2 report produced a sell-the-news response despite broadly strong numbers, including gross margins expanding to 54%. Whether the Q3 print clears a higher bar, and whether the macro backdrop around geopolitical risk and advanced-node capacity has shifted, is what the market will be focused on in the five weeks ahead.
See the live data behind this article on ORTEX.
Open 2330 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
